ANIX
Anixa Biosciences Inc
2.80$
+0.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -64.9% | 14.7% | -1,127.2% | -1,047.4% | -384.1% | -1,896.6% | – | -964.5% | -0.3% | -2,956.7% | – | – | |
| 8.6% | 3.6% | 119.5% | 101.7% | 30.9% | 186.5% | – | 11.7% | 0.0% | 21.9% | – | – | |
| 85.9% | 28.9% | 291.2% | 461.6% | 771.0% | 2,206.1% | – | 1,465.4% | 0.2% | 2,105.7% | – | – | |
| 154.5% | 29.7% | 301.6% | 57.2% | 566.3% | 1,591.9% | – | 1,538.9% | 0.3% | – | – | – | |
| -26.9% | -9.5% | -53.5% | 112.6% | 6.1% | 191.4% | – | 15.2% | 0.0% | -504.8% | – | – | |
| 0.2% | 0.6% | 48.8% | 8.3% | 3.5% | 70.2% | – | 0.0% | 0.0% | 0.0% | – | – | |
| -68.4% | 0.5% | 501.2% | -754.5% | 131.4% | -210.2% | – | -765.0% | -0.4% | -2,667.6% | – | – | |
| 0.4% | 0.0% | – | 0.0% | 0.0% | – | – | – | – | – | – | – | |
| 0.4% | -4.8% | 3.9% | -137.9% | 227.3% | 2,275.4% | – | – | 0.0% | 0.0% | – | – | |
| 95.4% | -32.4% | -1,000.0% | -827.6% | – | – | – | – | – | – | – | – | |
| 200.4% | -4.3% | -0.9% | 2,036.7% | 227.3% | 2,281.0% | – | 6,165.2% | 0.0% | 174.3% | – | – | |
| 67.2% | 10.9% | -627.0% | 234.8% | -25.5% | 174.3% | – | 4,435.7% | -0.7% | -5,450.0% | – | – | |
| -65.1% | 14.1% | -1,176.1% | -1,055.7% | -387.6% | -1,966.8% | – | -964.5% | -0.3% | -2,956.7% | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.